We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Artivion
AORT
$1.23B
| $34.5K | ﹤0.01% |
1,535
+543
| +55% | +$15.2K |
|
1627
Hexcel
HXL
$8.32B
| $34.4K | ﹤0.01% |
344
| – | – |
|
1628
Shift4
FOUR
$3.84B
| $34.4K | ﹤0.01% |
+707
| New | +$30.6K |
|
1629
Enlight Renewable Energy
ENLT
$12.2B
| $34.4K | ﹤0.01% |
+389
| New | +$34.3K |
|
1630
Prestige Consumer Healthcare
PBH
$2.35B
| $34.3K | ﹤0.01% |
726
+235
| +48% | +$12.1K |
|
1631
KBR
KBR
$4.68B
| $34.1K | ﹤0.01% |
989
-912
| -48% | -$31.8K |
|
1632
Selective Insurance
SIGI
$5.74B
| $34.1K | ﹤0.01% |
352
+82
| +30% | +$7.09K |
|
1633
Boston Properties
BXP
$11B
| $34.1K | ﹤0.01% |
514
+18
| +4% | +$1.08K |
|
1634
Lionsgate Studios
LION
$3.88B
| $34.1K | ﹤0.01% |
2,225
| – | – |
|
1635
National Vision
EYE
$1.6B
| $34K | ﹤0.01% |
1,789
+877
| +96% | +$17.9K |
|
1636
Usana Health Sciences
USNA
$394M
| $33.9K | ﹤0.01% |
1,588
+1,487
| +1,472% | +$28K |
|
|
GTLS
1637
DELISTED
Chart Industries
GTLS
| $33.8K | ﹤0.01% |
162
+21
| +15% | +$4.36K |
|
1638
Weyerhaeuser
WY
$17.3B
| $33.8K | ﹤0.01% |
1,412
+617
| +78% | +$15K |
|
1639
Enterprise Financial Services Corp
EFSC
$2.41B
| $33.7K | ﹤0.01% |
511
| – | – |
|
1640
Independent Bank
INDB
$4.05B
| $33.6K | ﹤0.01% |
401
| – | – |
|
1641
Erie Indemnity
ERIE
$11.7B
| $33.6K | ﹤0.01% |
140
+98
| +233% | +$22.5K |
|
1642
Caleres
CAL
$396M
| $33.5K | ﹤0.01% |
2,709
+470
| +21% | +$6.1K |
|
1643
Kirby Corp
KEX
$7.95B
| $33.3K | ﹤0.01% |
245
+5
| +2% | +$715 |
|
1644
Silgan Holdings
SLGN
$4.91B
| $33.3K | ﹤0.01% |
718
+125
| +21% | +$5K |
|
1645
Spire
SR
$4.92B
| $33.3K | ﹤0.01% |
426
+113
| +36% | +$9.71K |
|
1646
FTI Consulting
FCN
$4.82B
| $33.1K | ﹤0.01% |
222
-1,083
| -83% | -$177K |
|
1647
Gartner
IT
$9.41B
| $33.1K | ﹤0.01% |
255
-279
| -52% | -$42K |
|
1648
Southern California Bancorp
BCAL
$676M
| $33K | ﹤0.01% |
1,584
| – | – |
|
1649
Acadia Realty Trust
AKR
$2.99B
| $33K | ﹤0.01% |
1,578
-168
| -10% | -$3.59K |
|
1650
Boston Beer
SAM
$1.88B
| $32.9K | ﹤0.01% |
186
-1,172
| -86% | -$238K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.